Table 2 Demographic and clinical... | American Society of Hematology

Table 2

Demographic and clinical characteristics of patients with chronic ITP treated with eltrombopag

Patient No.	Sex/Age (y)	Disease duration (y)	Previous treatment	Platelet count (×10⁹/L)
Patient No.	Sex/Age (y)	Disease duration (y)	Previous treatment	Pretreatment	Posttreatment
1	M/25	2⁺	Steroid, VCR	13	112
2	M/24	4⁺	Steroids	12	5
3	M/51	2⁺	Steroids, IVIg	8	25
4	F/35	7⁺	Steroids	18	22
5	F/52	4⁺	Steroids, VCR	17	105
6	M/48	2^–	Steroids, VCR	4	167
7	F/63	2⁺	Steroids	12	15
8	F/24	1⁺	Steroids; IVIg	8	50
9	F/60	10⁺	Steroids, herbs	21	71
10	F/62	2⁺	Steroids	9	124
11	M/55	30⁺	Steroids	21	59
12	M/54	3⁺	Steroids	19	247
13	M/84	2⁺	Steroids, IVIg	7	37
14	F/58	4⁺	Steroids, herbs	19	51
15	M/59	3⁺	Steroids, IVIg, VCR	13	15
16	F/50	11⁺	Steroids, herbs	21	55
17	M/27	1⁺	Steroids	25	62
18	F/54	7⁺	Steroids, IVIg	22	69
19	F/42	1⁺	Steroids	17	57
20	F/44	2⁺	Steroids, IVIg, VCR	6	104
21	F/21	7⁺	Steroids, IVIg, VCR	4	33*

Patient No.	Sex/Age (y)	Disease duration (y)	Previous treatment	Platelet count (×10⁹/L)
Patient No.	Sex/Age (y)	Disease duration (y)	Previous treatment	Pretreatment	Posttreatment
1	M/25	2⁺	Steroid, VCR	13	112
2	M/24	4⁺	Steroids	12	5
3	M/51	2⁺	Steroids, IVIg	8	25
4	F/35	7⁺	Steroids	18	22
5	F/52	4⁺	Steroids, VCR	17	105
6	M/48	2^–	Steroids, VCR	4	167
7	F/63	2⁺	Steroids	12	15
8	F/24	1⁺	Steroids; IVIg	8	50
9	F/60	10⁺	Steroids, herbs	21	71
10	F/62	2⁺	Steroids	9	124
11	M/55	30⁺	Steroids	21	59
12	M/54	3⁺	Steroids	19	247
13	M/84	2⁺	Steroids, IVIg	7	37
14	F/58	4⁺	Steroids, herbs	19	51
15	M/59	3⁺	Steroids, IVIg, VCR	13	15
16	F/50	11⁺	Steroids, herbs	21	55
17	M/27	1⁺	Steroids	25	62
18	F/54	7⁺	Steroids, IVIg	22	69
19	F/42	1⁺	Steroids	17	57
20	F/44	2⁺	Steroids, IVIg, VCR	6	104
21	F/21	7⁺	Steroids, IVIg, VCR	4	33*

IVIg, intravenous immunoglobulin; VCR, vincristine.

+, more than; –,less than.

Patients whose platelets were ≥30 × 10⁹/L but showed petechial bleeding after therapy; steroids included high-dose dexamethasone (HD-DXM), prednisone, or methylprednisolone.

View Large

This Feature Is Available To Subscribers Only